̽»¨Ö±²¥Trinity Challenge has announced the winners of its inaugural competition, and is investing a £5.7 million (US$8 million) charitable pledged prize fund into one grand prize winner, two 2nd prize winners, and five 3rd prize winners.
A team of engineers has identified the ‘violent’ physical processes at work inside the lungs which cause wheezing, a condition that affects up to a quarter of the world’s population.
A computer vision technology developed by ̽»¨Ö±²¥ of Cambridge engineers has now been developed into a free mobile phone app for regular monitoring of glucose levels in people with diabetes.
A new type of artificial heart valve, made of long-lived polymers, could mean that millions of patients with diseased heart valves will no longer require lifelong blood-thinning medication after valve replacement surgery.
Cambridge-led study discovers new genetic causes of rare diseases, potentially leading to improved diagnosis and better patient care.
A new method of analysing cancer patients’ blood for evidence of the disease could be up to ten times more sensitive than previous methods according to new research led by the ̽»¨Ö±²¥ of Cambridge.
Scientists have created one of the most detailed maps of breast cancer ever achieved, revealing how genetic changes shape the physical tumour landscape, according to research funded published in .
Scientists at AstraZeneca, a global biopharmaceutical company, have been working with Cambridge ̽»¨Ö±²¥Â for more than two decades. What are the secrets of their success?
Study links the ‘weekend effect’ of increased hospital mortality to junior doctors admitting a lower proportion of healthy patients at the weekend compared to weekdays.
Dr Anna-Maria Pappa is a postdoctoral researcher in the Department of Chemical Engineering and Biotechnology and holds the Oppenheimer Research Fellowship and Maudslay-Butler Research Fellowship from Pembroke College. Her research is focused on the global challenge of antimicrobial resistance.Â
© 2025 ̽»¨Ö±²¥ of Cambridge